Nimoran P (50 ml) is a Fixed-Dose Combination (FDC) Drug Brand being manufactured and marketed by Perch Labs. Ltd.. This medicine is combination of more than one active ingredient or substance within a single pharmaceutical form type. The main active ingredients or salts in this drug are Paracetamol, Nimesulide. This drug comes in the form of Syrup. The general packing available for this medicine consists of 50 ml and is priced at Rs 24.8 (arround $0.3472 US Dollar)
Generic (Salt) Combination :
(Paracetamol+ Nimesulide)
Pharma Company :
Perch Labs. Ltd.
Brand Label :
Nimoran P (50 ml)
Preparation Type :
Syrup
Single Dose :
5 ml
Composition (Fixed-Dose Combination) :
Paracetamol-125 mg
Nimesulide-100 mg
Pack Size/Qty/Vol :
50 ml
Price Unit :
Rs 2.48 INR (arround $0.03472 US Dollar)
Price Pack :
Rs 24.8 INR (arround $0.3472 US Dollar)
Drug details for Nimoran P (50 ml)
Usage: Why is this medication prescribed?
The main active ingredients or salts in Nimoran P (50 ml) are :
Paracetamol-125 mg
Nimesulide-100 mg
Paracetamol Indication (Prescribed for or used as): Analgesic and antipyretic.
For more details on Paracetamol, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Paracetamol..
Nimesulide Indication (Prescribed for or used as): Analgesic and antipyretic. Rheumatoid arthritis, osteoarthritis, other degenerative joint disorders. Musculo skeletal disorders. Thrombophlebitis.
For more details on Nimesulide, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Nimesulide..
Nimoran P (50 ml) Drug Brands Substitutes with similar Fixed-Dose Combination (FDC) :
There are 7 Fixed-Dose Combination (FDC) Drug Brands listed here as Substitutes for Nimoran P (50 ml), which have same Fixed-Dose Combination of active substances or ingredients (i.e. Paracetamol-125 mg Nimesulide-100 mg). Please note that one can request a doctor or pharmacist to substitute a FDC Brand Version of the prescribed FDC drug brand, if any. Fixed-Dose Combination Drugs are being increasingly used due to the benefit of the combined effects of active ingredients given together. However, it is necessary to investigate the possible benefits in the clinical situation against possible disadvantages for each fixed combination drug and for each dose of the fixed combination drug. Potential advantages of fixed combination drugs may also include the counteracting by one ingredient of an adverse reaction produced by another one, and simplification of therapy, leading to improved compliance.